2상모집 중
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
연구 개요
This study is researching experimental drugs called ALN-ANG3 and evinacumab (called "study drugs"). The study is focused on participants who have diabetic kidney disease. The aim of the study is to see how safe and effective the study drugs are. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times
- 스폰서
- 리드: 리제네론
- 적응증
- Diabetic Kidney Disease (DKD)
- 중재
- ALN-ANG3, Evinacumab, ALN-ANG3 placebo, Evinacumab placebo
- 목표 등록
- 270명
- 시작일
- 2026-01-09
- 완료(예정)
- 2028-04-07
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.